| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Pacific Biosciences of California Inc (NASDAQ: PACB)
PACB Technical Analysis
5
| As on 24th Dec 2024 PACB STOCK Price closed @ 1.95 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 6.98 & Strong Sell for SHORT-TERM with Stoploss of 11.38 we also expect STOCK to react on Following IMPORTANT LEVELS. |
PACBSTOCK Price
| Open | 1.95 | Change | Price | % |
| High | 1.96 | 1 Day | 0.02 | 1.04 |
| Low | 1.87 | 1 Week | -0.01 | -0.51 |
| Close | 1.95 | 1 Month | -0.51 | -20.73 |
| Volume | 2552603 | 1 Year | -11.93 | -85.95 |
| 52 Week High 13.93 | 52 Week Low 1.20 | ||||
NASDAQ USA Most Active Stocks
| AMRS | 0.14 | 100.00% |
| LMDX | 0.02 | 0.00% |
| LCID | 3.20 | 3.23% |
| AVGR | 1.45 | 126.56% |
| NVDA | 140.22 | 0.39% |
| AKTS | 0.04 | 0.00% |
| TNXP | 0.39 | -2.50% |
| PONO | 1.72 | 2.38% |
| TELL | 1.00 | 0.00% |
| TSLA | 462.28 | 7.36% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| PACB Daily Charts |
PACB Intraday Charts |
Whats New @ Bazaartrend |
PACB Free Analysis |
|
|
PACB Important Levels Intraday
| RESISTANCE | 2.12 |
| RESISTANCE | 2.07 |
| RESISTANCE | 2.03 |
| RESISTANCE | 2.00 |
| SUPPORT | 1.90 |
| SUPPORT | 1.87 |
| SUPPORT | 1.83 |
| SUPPORT | 1.78 |
PACB Forecast December 2024
| 4th UP Forecast | 9.27 |
| 3rd UP Forecast | 6.92 |
| 2nd UP Forecast | 5.47 |
| 1st UP Forecast | 4.02 |
| 1st DOWN Forecast | -0.12 |
| 2nd DOWN Forecast | -1.57 |
| 3rd DOWN Forecast | -3.02 |
| 4th DOWN Forecast | -5.37 |
PACB Weekly Forecast
| 4th UP Forecast | 5.69 |
| 3rd UP Forecast | 4.49 |
| 2nd UP Forecast | 3.75 |
| 1st UP Forecast | 3.01 |
| 1st DOWN Forecast | 0.89 |
| 2nd DOWN Forecast | 0.15 |
| 3rd DOWN Forecast | -0.59 |
| 4th DOWN Forecast | -1.79 |
PACB Forecast2024
| 4th UP Forecast | 27.75 |
| 3rd UP Forecast | 19.48 |
| 2nd UP Forecast | 14.36 |
| 1st UP Forecast | 9.25 |
| 1st DOWN Forecast | -5.35 |
| 2nd DOWN Forecast | -10.46 |
| 3rd DOWN Forecast | -15.58 |
| 4th DOWN Forecast | -23.85 |
Pacific Biosciences of California Inc ( NASDAQ USA Symbol : PACB )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
PACB Business Profile
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits designed for specific workflow, such as template preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonucleases. It also offers binding kits, such as modified DNA polymerase used to bind SMRTbell libraries to the polymerase in preparation for sequencing; and sequencing kits comprise reagents required for on-instrument, real-time sequencing, including the phospholinked nucleotides. The company serves research institutions; commercial laboratories; genome centers; clinical, government, and academic institutions; genomics service providers; pharmaceutical companies; and agricultural companies. It markets its products through a direct sales force in North America and Europe, as well as through distribution partners in Asia, Europe, the Middle East, Africa, and Latin America. Pacific Biosciences of California, Inc. has a collaboration with Invitae Corporation to develop ultra-high-throughput clinical whole genome sequencing platform; and a research collaboration with Rady Children's Institute for Genomic Medicine for whole genome sequencing platform. The company was formerly known as Nanofluidics, Inc. and changed its name to Pacific Biosciences of California, Inc. in 2005. Pacific Biosciences of California, Inc. was incorporated in 2000 and is headquartered in Menlo Park, California. Address: 1305 O?Brien Drive, Menlo Park, CA, United States, 94025
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service